Medications

Allergan, Pfizer call off proposed $160B merger

Top U.S. drugmaker Pfizer and Irish rival Allergan are charting independent futures after scrapping a record $160 billion deal torpedoed by new Treasury Department rules meant to block American companies from moving their ...

Apr 06, 2016
popularity1 comments 0